Payment for Oncolytics in the United States: A History of Buy and Bill and Proposals for Reform-Reference-Cited by-同舟云学术

Payment for Oncolytics in the United States: A History of Buy and Bill and Proposals for Reform

Published:2014-11 Issue:6 Volume:10 Page:357-362
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Polite Blase N.¹,Ward Jeffery C.¹,Cox John V.¹,Morton Roscoe F.¹,Hennessy John¹,Page Ray D.¹,Conti Rena M.¹

Affiliation:

1. University of Chicago Medicine; University of Chicago, Chicago, IL; Swedish Cancer Institute, Edmonds, WA; Texas Oncology–Methodist, Dallas; Center for Cancer and Blood Disorders, Fort Worth, TX; Medical Oncology and Hematology Associates, Des Moines, IA; and Sarah Cannon Cancer Center, Nashville, TN

Abstract

The authors review and discuss the opportunities and challenges raised by policy options for Average Sales Price reform or replacement.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2014.001958

Reference22 articles.

1. National Oncology Practice Benchmark, 2012 Report on 2011 Data

2. The National Practice Benchmark for Oncology, 2013 Report on 2012 Data

3. Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists